Zepp Health Corporation

NYSE:ZEPP

Consumer Electronics

Technology
$3.55 -0.58%

-$0.03 today

Market cap
$50.84M
Beta
1.78
P/E (TTM)
-0.1
EPS (TTM)
-$282.07
52W Low $2.36High $61.85

Volume 0.04M

Average 0.13M

ZEPP Operating Income

Profit from core operations after operating expenses, before interest and taxes.

Zepp Health CorporationNYSE: ZEPP

Operating Income · Q1 FY2026 · quarter ended Mar 2026

Operating income remains negative

Q1 FY2026 operating income was -CN¥122.13M, compared with -CN¥133.45M a year earlier. Trailing-twelve-month operating income was -CN¥199.46M.

Context

  • Operating income amounted to 11.3% of revenue in FY2025, down 14.6 pp from a year earlier.
  • Operating income grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether operating income reaches the consensus estimate from 1 analysts of CN¥28.38M (+113.8%) for the fiscal year ending Dec 2026, a step up from the +40.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-CN¥122.13M-349.2% QoQ
Last fiscal yearDec 2025
-CN¥204.93M+40.6% YoY
LTMMar 2026
-CN¥199.46M+44.3% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.5%——
1 year+40.6%+113.8%+73.2 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

CNY · from the income statement

Latest · FY2025
(204.93M) CNY
Year-over-year change
+40.6%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How ZEPP compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +44.3% is the 4th highest of 8, against a peer median of +40.9%.
  • Operating income amounts to 10.4% of revenue for ZEPP, versus a peer median of 32.9%.
ZEPP Competitors
Operating Income for ZEPP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TTECTTEC Holdings, Inc.LTM Mar 2026$88.87M USD+152.6%-17.1%4.2%
BWBabcock & Wilcox Enterprises, Inc.LTM Mar 2026$28.24M USD+40.9%—4.2%
TROOTROOPS, Inc.FY2025-$16.69M USD-191.3%—97.6%
EXFYExpensify, Inc.LTM Mar 2026-$18.5M USD-3493.0%—13.2%
SVCOSilvaco Group, Inc. Common StockLTM Mar 2026-$30.45M USD+51.1%—45.6%
KULRKULR Technology Group, Inc.LTM Mar 2026-$40.55M USD-102.5%—218.4%
STEMStem, Inc.LTM Mar 2026-$50.24M USD+93.7%—32.9%
ZEPPZepp Health CorporationLTM Mar 2026-CN¥199.46M CNY+44.3%—10.4%
Peer median (excluding ZEPP) —+40.9%-17.1%32.9%

Competitors are the stored peer set for ZEPP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6.17B4.22B2.5B1.33B1.82B
Cost of Revenue4.88B3.4B1.84B820.57M1.1B
Gross Profit1.29B817.22M653.7M512.88M711.63M
Gross Margin20.9%19.4%26.2%38.5%39.2%
Research & Development508.41M526.2M364.53M337.07M317.73M
Selling, General & Admin687.6M708.46M504.69M520.85M582.64M
Operating Expenses1.2B1.23B869.22M857.92M916.56M
Depreciation & Amortization51.21M59.65M54.43M36.64M31.71M
EBITDA200.8M(261.43M)(142.88M)(345.66M)(191.48M)
EBITDA Margin3.3%-6.2%-5.7%-25.9%-10.5%
Operating Income92.73M(417.45M)(215.52M)(345.04M)(204.93M)
Operating Margin1.5%-9.9%-8.6%-25.9%-11.3%
Interest Income16.47M12.55M21.86M26.81M10.7M
Interest Expense44.3M58M47.79M40.54M39.94M
Other Income / Expenses53.06M56.34M(21.7M)(108.55M)(58.2M)
Income Before Tax145.78M(361.11M)(237.22M)(453.59M)(263.13M)
Pre-Tax Margin2.4%-8.6%-9.5%-34.0%-14.5%
Income Tax Expense10.61M(67.03M)(17.2M)99.99M17.79M
Net Income136.02M(293.37M)(220.49M)(554.13M)(280.92M)
Net Margin2.2%-7.0%-8.8%-41.6%-15.5%
EPS (Basic)1.38(2.71)(1.96)(34.16)(283.04)
EPS (Diluted)1.31(2.71)(1.96)(34.16)(283.04)
Weighted Avg Shares15.76M15.39M15.2M16.18M993.87K
Weighted Avg Shares (Diluted)16.52M15.39M15.2M16.18M993.87K

Zepp Health Corporation

NYSE:ZEPP

Intrinsic Alpha fair value

Locked

Current Price

$3.55

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.